Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillaume Bassez

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
The Journal of Clinical Investigation|September 4, 2019
Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and miceArnaud F Klein, Miguel A Varela, Ludovic Arandel, et al.
Brain : a Journal of Neurology|June 25, 2004
A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24Isabelle Le Ber, Maria Martinez, Dominique Campion, et al.
Neuromuscular Disorders : NMD|December 17, 2013
Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophiesLinda L Bachinski, Keith A Baggerly, Valerie L Neubauer, et al.
BMJ Open|January 31, 2023
Patient-reported burden of myasthenia gravis: baseline results of the international prospective, observational, longitudinal real-world digital study MyRealWorld-MGSarah Dewilde, Glenn Philips, Sandra Paci, et al.
Molecular Therapy. Nucleic Acids|November 4, 2015
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide MetforminDelphine Laustriat, Jacqueline Gide, Laetitia Barrault, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 5, 2015
Construction of a Quality of Life Questionnaire for slowly progressive neuromuscular diseaseAntoine Dany, Coralie Barbe, Amandine Rapin, et al.
JAMA Neurology|February 7, 2018
Development and Validation of a New Scoring System to Predict Survival in Patients With Myotonic Dystrophy Type 1Karim Wahbi, Raphaël Porcher, Pascal Laforêt, et al.
Muscle & Nerve|October 7, 2021
Determinants of diaphragm inspiratory motion, diaphragm thickening, and its performance for predicting respiratory restrictive pattern in Duchenne muscular dystrophyAbdallah Fayssoil, Lee S Nguyen, Tanya Stojkovic, et al.
Journal of Neuromuscular Diseases|December 20, 2018
Echographic Assessment of Diaphragmatic Function in Duchenne Muscular Dystrophy from Childhood to AdulthoodAbdallah Fayssoil, Cendrine Chaffaut, Adam Ogna, et al.
The Lancet. Neurology|June 24, 2018
Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trialKees Okkersen, Cecilia Jimenez-Moreno, Stephan Wenninger, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
The Journal of Clinical Investigation|September 4, 2019
Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and miceArnaud F Klein, Miguel A Varela, Ludovic Arandel, et al.
Brain : a Journal of Neurology|June 25, 2004
A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24Isabelle Le Ber, Maria Martinez, Dominique Campion, et al.
Neuromuscular Disorders : NMD|December 17, 2013
Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophiesLinda L Bachinski, Keith A Baggerly, Valerie L Neubauer, et al.
BMJ Open|January 31, 2023
Patient-reported burden of myasthenia gravis: baseline results of the international prospective, observational, longitudinal real-world digital study MyRealWorld-MGSarah Dewilde, Glenn Philips, Sandra Paci, et al.
Molecular Therapy. Nucleic Acids|November 4, 2015
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide MetforminDelphine Laustriat, Jacqueline Gide, Laetitia Barrault, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 5, 2015
Construction of a Quality of Life Questionnaire for slowly progressive neuromuscular diseaseAntoine Dany, Coralie Barbe, Amandine Rapin, et al.
JAMA Neurology|February 7, 2018
Development and Validation of a New Scoring System to Predict Survival in Patients With Myotonic Dystrophy Type 1Karim Wahbi, Raphaël Porcher, Pascal Laforêt, et al.
Muscle & Nerve|October 7, 2021
Determinants of diaphragm inspiratory motion, diaphragm thickening, and its performance for predicting respiratory restrictive pattern in Duchenne muscular dystrophyAbdallah Fayssoil, Lee S Nguyen, Tanya Stojkovic, et al.
Journal of Neuromuscular Diseases|December 20, 2018
Echographic Assessment of Diaphragmatic Function in Duchenne Muscular Dystrophy from Childhood to AdulthoodAbdallah Fayssoil, Cendrine Chaffaut, Adam Ogna, et al.
The Lancet. Neurology|June 24, 2018
Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trialKees Okkersen, Cecilia Jimenez-Moreno, Stephan Wenninger, et al.
Pageof 10